Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001415889-25-006154

Options or other derivatives

  • CHIEF LEGAL OFFICER acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mitchell Shawnte CHIEF LEGAL OFFICER 2025-02-28 Grant or award · Stock Option (Right to Buy) +450,000 450,000 D
Loading xslF345X05/form4-03032025_090314.xml…